CUSIP 81750R102COMMCRBQ1 2025
Aggregate 13F value by quarter
Multi-quarter trend — upgrade to see history
UpgradeQ1 2025
59 funds hold this security · Q1 2025
| # | Fund | Shares | Value | Δ Shares | Activity |
|---|---|---|---|---|---|
| 1 | Flagship Pioneering, LLC | 23.12M | $16.18M | +23.12M | New Position |
| 2 | Fmr LLC | 21.89M | $15.32M | +21.89M | New Position |
| 3 | Vanguard Group Inc | 6.09M | $4.26M | +6.09M | New Position |
| 4 | Blackrock, Inc. | 1.76M | $1.23M |
| +1.76M |
| New Position |
| 5 | Geode Capital Management, LLC | 1.62M | $1.13M | +1.62M | New Position |
| 6 | Ubs Group AG | 1.46M | $1.02M | +1.46M | New Position |
| 7 | Vontobel Holding Ltd. | 1.09M | $760.3K | +1.09M | New Position |
| 8 | Charles Schwab Investment Management Inc | 834.1K | $584.0K | +834.1K | New Position |
| 9 | Susquehanna International Group, LLP | 717.1K | $502.1K | +717.1K | New Position |
| 10 | State Street Corp | 500.7K | $350.6K | +500.7K | New Position |
See every fund holding Seres Therapeutics Inc, with full quarter-over-quarter share changes.
Unlock all holders